Related Experiment Video
Updated: Sep 2, 2025

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
Published on: August 3, 2021
Survival in Cystic Fibrosis: Trends, Clinical Factors, and Prediction Models
Melanie Chin1, Karen Earlam1, Shawn D Aaron2
1Department of Medicine, University of Ottawa, Ottawa, Canada.
Insights
Survival for cystic fibrosis (CF) patients has improved, but respiratory failure remains a challenge. Understanding survival trends and predictive models is crucial for lung transplant decisions in CF care.
Area of Science:
- Medical Genetics
- Pulmonology
- Transplant Surgery
Background:
- Cystic fibrosis (CF) is a genetic disorder causing severe health complications and reduced lifespan.
- Advances in diagnosis, nutrition, and treatment have significantly improved CF patient survival over 40 years.
- Respiratory failure remains the primary cause of death in CF patients, necessitating lung transplantation for the sickest individuals.
Purpose of the Study:
- To review changes in CF survival over four decades.
- To identify clinical factors influencing CF patient survival.
- To examine predictive models for CF survival and lung transplant timing.
Main Methods:
- Literature review of studies on cystic fibrosis survival.
- Analysis of clinical factors associated with CF outcomes.
- Evaluation of prognostic models for CF and lung transplantation.
Main Results:
- Significant improvements in CF survival documented over the past 40 years.
- Key clinical factors impacting CF survival identified.
- Predictive models for CF prognosis and lung transplant candidacy discussed.
Conclusions:
- While CF survival has improved, lung transplantation remains vital for extending life in severe cases.
- Accurate survival prediction models are essential for optimizing lung transplant selection and timing in CF patients.
- Continued research into CF progression and transplant outcomes is critical for enhancing patient longevity.
Abstract:
Cystic fibrosis (CF) is an autosomal recessive genetic disease that results in multiple medical complications, and ultimately decreased survival of affected patients. Due to multiple advances in early diagnosis, nutrition, and aggressive treatment of complications, survival of these patients has improved dramatically in the past 40 years. However, despite improved care, patients still die at a relatively young age, most commonly due to respiratory failure. In order to extend survival, the sickest patients with CF are considered for lung transplant. An accurate understanding of a CF patient's expected survival and health trajectory is critical for appropriate patient selection and timing of transplantation. This review discusses how survival in CF has changed over the past four decades, the clinical factors that are associated with survival, as well as the use of models to predict survival and optimal timing of lung transplant in patients with CF.
More Related Videos
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cancer Survival Analysis
Assumptions of Survival Analysis
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Survival Tree
Building a Survival Tree
Constructing a...